This information is about a specific type of non-Hodgkin's lymphoma (NHL), known as anaplastic large cell lymphoma. It should ideally be read with our general information about non-Hodgkin's lymphoma.
Skip the main content if you do not want to read it as the next section.
Skip the location trail if you do not want to read it as the next section.
Location trail
CANCER TYPE > LYMPHOMA, NON-HODGKIN > TYPES OF NHL > ANAPLASTIC LARGE CELLAnaplastic large cell lymphoma
Anaplastic large cell lymphoma
Anaplastic large cell lymphoma is rare, accounting for about 1 in 50 of all cases. It can occur at any time between childhood and old age, but is most common in children and young adults. It is about twice as common in men as in women. The lymphoma is usually made up of T-lymphocytes, although in some cases the type of cell making up the lymphoma is unclear – this is known as null-cell type.
Diagram showing lymphatic system
Causes
The causes of anaplastic large cell lymphoma are unknown. Anaplastic large cell lymphoma, like other cancers, is not infectious and cannot be passed on to other people.
Signs and symptoms
The first sign of the condition is often a painless swelling in the neck, armpit or groin, caused by enlarged lymph nodes. More than one group of nodes are often affected. This lymphoma may also occur in skin and sometimes in other organs such as the lungs, liver, bone marrow or bones. Some people experience a loss of appetite and tiredness.
Other symptoms, known as B symptoms, include night sweats, unexplained high temperatures, and weight loss.
How it is diagnosed
A diagnosis is made by removing an enlarged lymph node, or part of it, and examining the cells under a microscope (this is called a biopsy). You will be referred to a surgeon for this procedure. It is a very small operation and may be done under local or general anaesthetic. Biopsies may also be taken from other body tissues.
Additional tests, including blood tests, x-rays, scans, and bone marrow samples are then used to get more information about the type of lymphoma and how far it has spread in the body. This information is used to help decide which treatment is most appropriate for you.
Staging and grading
Staging
The stage of NHL describes how many groups of lymph nodes are affected, where they are in the body, and whether other organs such as the bone marrow or liver are involved.
- Stage 1 The lymphoma is only in one group of lymph nodes, in one particular area of the body.
- Stage 2 More than one group of lymph nodes is affected, but all the affected nodes are contained within either the upper half or the lower half of the body. The upper half of the body is above the diaphragm (the sheet of muscle underneath the lungs), and the lower half is below the diaphragm.
- Stage 3 Lymphoma is present in lymph nodes in both the upper and lower parts of the body (ie in lymph nodes both above and below the diaphragm). Your spleen is considered as a lymph node in this staging system.
- Stage 4 The lymphoma has spread beyond lymph nodes to other lymphatic organs – for example, to sites such as the bone marrow, liver or lungs.
The stage usually includes the letter A or B, which describes whether or not any B symptoms are present (eg stage 2B). Sometimes the lymphoma can start in areas outside the lymph nodes, and this is represented by the letter E, which stands for extranodal (eg stage 3AE).
Grading
For practical purposes, non-Hodgkin's lymphomas are also divided into two groups: low- and high-grade. Low-grade lymphomas are usually slow-growing and high-grade lymphomas tend to grow more quickly.
Anaplastic large cell lymphoma is a high-grade lymphoma. This means that it is faster-growing and usually needs prompt treatment with chemotherapy.
Treatment
Chemotherapy
Chemotherapy is the use of anti-cancer (cytotoxic) drugs to destroy cancer cells. Anaplastic large cell lymphoma usually needs intensive treatment with chemotherapy. A combination of drugs is given into a vein through injections or drips. Several different combinations of drugs have been used to treat this condition and they appear to be equally successful.
This type of lymphoma usually responds well to chemotherapy, and the lymphoma may seem to disappear completely. This is known as a remission. However, there is a risk that it may come back in the future. In this situation further chemotherapy can be given to try to control it.
Radiotherapy
Radiotherapy is the use of high-energy rays to destroy cancer cells, while doing as little harm as possible to healthy cells. It may be used alone when the lymphoma cells are contained in one area of lymph nodes (stage 1). However, radiotherapy is more commonly given after chemotherapy.
High-dose treatment with stem cell support
High-dose chemotherapy with bone marrow or stem cell infusions have been used for some people with this type of lymphoma. This treatment involves very intensive chemotherapy and sometimes radiotherapy.
As side effects can be severe, some types of high-dose treatment are not given to people over the age of 45–50, while others can be given to people of up to 65 years who are fit enough. The intensity of the treatment increases the risk of serious side effects for people over this age.
Steroid therapy
Steroids are drugs which are often given with chemotherapy to help treat lymphomas. They also help you to feel better and can reduce feelings of sickness.
Clinical trials
New treatments for anaplastic large cell lymphoma are being researched all the time, and you might be invited by your doctor to take part in a clinical trial to compare a new treatment against the best available standard treatment. Your doctor must discuss the treatment with you, and have your informed consent before entering you into any clinical trial.
Support
Everyone has their own way of dealing with their illness and the different emotions they experience. Some people find it helpful to talk things over with family and friends or their doctor or nurse. You can also contact our cancer information nurse specialists or another support organisation for more information and support.
References
This section has been compiled using information from a number of reliable sources, including:
- Oxford Textbook of Oncology (2nd edition). Eds Souhami et al. Oxford University Press, 2002.
- Wintrobe’s Clinical Haematology (12th edition). Eds Lee et al. Williams and Wilkins, 2008.
- Improving outcomes in Haemato-oncology. National Institute for Health and Clinical Excellence (NICE), November 2003.
For further references, please see the general bibliography.
Content last reviewed: 01 April 2009
Page last modified: 12 June 2009
Page last modified: 12 June 2009
